Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (12354)	12/9/1997 8:48:00 AM
From: CYBERKEN	Respond to of 32384

Their only motivation in selling would be that they simply aren't in the business of investing in biotechnology companies, and must therefore convert their profit to cash and move on. The possibility I didn't mention is that they might actually decide that Ligand is undervalued (a real no-brainer, IMO) and hang on to LGNDW until Ligand reaches the next tier. This is possible since they don't HAVE to dispose of the warrants for 2 1/2 years. The most pessimistic realistic scenario would have to put Ligand at 30-40 in mid 2000.